MX2023004955A - Compuestos de aminotiazol deuterados como compuestos antiviricos. - Google Patents

Compuestos de aminotiazol deuterados como compuestos antiviricos.

Info

Publication number
MX2023004955A
MX2023004955A MX2023004955A MX2023004955A MX2023004955A MX 2023004955 A MX2023004955 A MX 2023004955A MX 2023004955 A MX2023004955 A MX 2023004955A MX 2023004955 A MX2023004955 A MX 2023004955A MX 2023004955 A MX2023004955 A MX 2023004955A
Authority
MX
Mexico
Prior art keywords
compounds
deuterated
aminothiazole
antiviral
antiviral compounds
Prior art date
Application number
MX2023004955A
Other languages
English (en)
Inventor
Christian Gege
Gerald Kleymann
Original Assignee
Innovative Molecules Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Molecules Gmbh filed Critical Innovative Molecules Gmbh
Publication of MX2023004955A publication Critical patent/MX2023004955A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a nuevos compuestos deuterados de Fórmula (I) (ver Fórmula), a un proceso para su preparación y a su uso como medicamentos, en particular como medicamento antivíricos.
MX2023004955A 2020-10-29 2021-10-28 Compuestos de aminotiazol deuterados como compuestos antiviricos. MX2023004955A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20204545 2020-10-29
PCT/EP2021/080023 WO2022090409A1 (en) 2020-10-29 2021-10-28 Deuterated aminothiazole compounds as antiviral compounds

Publications (1)

Publication Number Publication Date
MX2023004955A true MX2023004955A (es) 2023-05-17

Family

ID=73037895

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023004955A MX2023004955A (es) 2020-10-29 2021-10-28 Compuestos de aminotiazol deuterados como compuestos antiviricos.

Country Status (9)

Country Link
US (1) US20230391738A1 (es)
EP (1) EP4237414A1 (es)
JP (1) JP2023552274A (es)
KR (1) KR20230131177A (es)
CN (1) CN116783171A (es)
AU (1) AU2021367976A1 (es)
CA (1) CA3196645A1 (es)
MX (1) MX2023004955A (es)
WO (1) WO2022090409A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023135303A1 (en) 2022-01-17 2023-07-20 Innovative Molecules Gmbh Solid crystalline forms of helicase-primase inhibitors and process of preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DOP2000000109A (es) 1999-12-23 2002-08-30 Gerald Kleymann Derivados de tiazolilamida
MX2018012116A (es) 2016-04-06 2019-05-23 Innovative Molecules Gmbh Derivados de aminotiazol utiles como agentes antiviricos.
CN111433203B (zh) 2017-10-05 2024-02-13 创新分子股份有限公司 作为抗病毒化合物的取代噻唑的对映异构体
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑

Also Published As

Publication number Publication date
CA3196645A1 (en) 2022-05-05
CN116783171A (zh) 2023-09-19
EP4237414A1 (en) 2023-09-06
AU2021367976A1 (en) 2023-06-08
WO2022090409A1 (en) 2022-05-05
JP2023552274A (ja) 2023-12-15
US20230391738A1 (en) 2023-12-07
KR20230131177A (ko) 2023-09-12

Similar Documents

Publication Publication Date Title
PH12020551762A1 (en) Peptide macrocycles against acinetobacter baumannii
MX2021006421A (es) Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
PH12021550310A1 (en) Novel sulfonamideurea compounds
MD4736C1 (ro) Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MX2017012393A (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
MD20140037A2 (ro) Derivaţi de (4-fenilimidazol-2-il)etilamină utili ca modulatori ai canalului de sodiu
MX2020005079A (es) Derivados de aminotiazol utiles como agentes antiviricos.
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
MX2021015056A (es) Compuesto de pirrolopirimidina y uso del mismo.
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
PH12015502429A1 (en) Dicarboxylic acid compound
MD20160105A2 (ro) 2-Amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8H)-il-1,3-tiazol-4-il amide
CR20210460A (es) Compuestos útiles en la terapia del vih
MX2021009659A (es) Hidroxipiridoxazepinas como activadores de nrf2.
PH12015502684A1 (en) New compounds having triple activities of thrombolysis, antithrombotic and radical scavenging, and synthesis, nano-structure and use thereof
TN2021000025A1 (en) Novel heterocyclic amine derivative and pharmaceutical composition comprising same
MX2021003739A (es) Derivados de quinolino-pirrolidin-2-ona como inhibidores del gen mutado de ataxia telangiectasia (atm) y el uso de los mismos en el tratamiento de tumores sólidos.
MX2023004955A (es) Compuestos de aminotiazol deuterados como compuestos antiviricos.
JOP20210063A1 (ar) مشتقات جديدة من أمينو- بيريميدونيل- بيبريدينيل، وعملية لتحضيرها وتركيبات صيدلانية تحتوي عليها
GEP20247626B (en) Industrial process for the preparation of high purity estetrol
MX2021009170A (es) Cristal de compuesto de diariltiohidantoina.
MX2023006231A (es) Inhibidores de enzimas.
MX2023001723A (es) Derivados ciclicos de quemerina-9.